Ruze R - Search Results

1

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.

Chen Y, Xu R, Ruze R, Yang J, Wang H, Song J, You L, Wang C, Zhao Y. Chen Y, et al. Among authors: ruze r. Cancer Cell Int. 2021 Jun 5;21(1):291. doi: 10.1186/s12935-021-01928-6. Cancer Cell Int. 2021. PMID: 34090418 Free PMC article.

2

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer.

Chen Y, Wang C, Song J, Xu R, Ruze R, Zhao Y. Chen Y, et al. Among authors: ruze r. Front Immunol. 2021 Nov 23;12:758004. doi: 10.3389/fimmu.2021.758004. eCollection 2021. Front Immunol. 2021. PMID: 34887861 Free PMC article.

3

Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer.

Wang C, Chen Y, Xinpeng Y, Xu R, Song J, Ruze R, Xu Q, Zhao Y. Wang C, et al. Among authors: ruze r. BMC Cancer. 2022 Aug 11;22(1):879. doi: 10.1186/s12885-022-09927-0. BMC Cancer. 2022. PMID: 35953822 Free PMC article.

4

Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.

Song J, Ruze R, Chen Y, Xu R, Yin X, Wang C, Xu Q, Zhao Y. Song J, et al. Among authors: ruze r. BMC Cancer. 2022 Aug 16;22(1):894. doi: 10.1186/s12885-022-09983-6. BMC Cancer. 2022. PMID: 35974300 Free PMC article.

5

Lipid metabolism in pancreatic cancer: emerging roles and potential targets.

Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, Xu Q. Yin X, et al. Among authors: ruze r. Cancer Commun (Lond). 2022 Dec;42(12):1234-1256. doi: 10.1002/cac2.12360. Epub 2022 Sep 15. Cancer Commun (Lond). 2022. PMID: 36107801 Free PMC article. Review.

6

The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.

Yin X, Chen Y, Ruze R, Xu R, Song J, Wang C, Xu Q. Yin X, et al. Among authors: ruze r. Signal Transduct Target Ther. 2022 Sep 16;7(1):324. doi: 10.1038/s41392-022-01178-6. Signal Transduct Target Ther. 2022. PMID: 36114195 Free PMC article. Review.

7

Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis.

Wang C, Xu R, Song J, Chen Y, Yin X, Ruze R, Xu Q. Wang C, et al. Among authors: ruze r. Front Oncol. 2022 Sep 12;12:1004850. doi: 10.3389/fonc.2022.1004850. eCollection 2022. Front Oncol. 2022. PMID: 36172154 Free PMC article.

8

Obesity, diabetes mellitus, and pancreatic carcinogenesis: Correlations, prevention, and diagnostic implications.

Ruze R, Chen Y, Xu R, Song J, Yin X, Wang C, Xu Q. Ruze R, et al. Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188844. doi: 10.1016/j.bbcan.2022.188844. Epub 2022 Dec 1. Biochim Biophys Acta Rev Cancer. 2023. PMID: 36464199 Review.

9

Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.

Ruze R, Song J, Yin X, Chen Y, Xu R, Wang C, Zhao Y. Ruze R, et al. Signal Transduct Target Ther. 2023 Mar 24;8(1):139. doi: 10.1038/s41392-023-01376-w. Signal Transduct Target Ther. 2023. PMID: 36964133 Free PMC article.

10

Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments.

Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, Xu Q. Ruze R, et al. Front Endocrinol (Lausanne). 2023 Apr 21;14:1161521. doi: 10.3389/fendo.2023.1161521. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152942 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters